Varewijck, A J <br/><br/>
Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir.  [electronic resource] 

 -  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society  Dec 2010 
 - 427-31 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1532-2238 
<br/><br/><label>Standard No.: </label>10.1016/j.ghir.2010.10.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD--metabolism<br/>Cells, Cultured<br/>Dose-Response Relationship, Drug<br/>Enzyme Activation--drug effects<br/>Enzyme Assays--methods<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--analogs & derivatives<br/>Insulin Detemir<br/>Insulin Glargine<br/>Insulin, Long-Acting<br/>Osmolar Concentration<br/>Receptor, IGF Type 1--agonists<br/>Receptor, Insulin--agonists